NEW YORK, February 17 /PRNewswire-FirstCall/ -- SPO Medical Inc. (OTC: SPOM - News), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today that it has appointed Med Tech and Med Care Associates as its new independent sales representative group for the US market.
Med Tech and Med Care Associates (MTA/MCA) are independent sales organizations serving the healthcare industry and operate with manufacturers of medical products and devices as their field sales representatives and agents. For SPO Medical MTA/MCA will focus on sales in the US medical professional market and development of the distribution channels for the SPO Medical PulseOx 6000(TM) finger oximeter unit, PulseOx 6100(TM) handheld oximeter unit with interchangeable adult and pediatric sensors and the PulseOx 7500(TM) product line for prescreening of Sleep Apnea.
Michael Braunold, President and Chief Executive Officer of SPO Medical commented: "With increasing challenges in worldwide markets, we sought to extend our reach in the US as our primary market. Through MTA/MCA, we now have an additional 40 experienced and professional sales representatives with expanded coverage throughout the US market. This should vastly extend our distribution capability to medical facilities we could not reach before and strengthen our overall presence and penetration in the territory."
Dennis Snedden, President of MTA commented: "We are pleased to add SPO Medical as one of the manufacturers our team represents. SPO's reputation for their products and customer service is a perfect match for the commitment and support that MTA/MCA is renowned for, with its customer base of leading distributors to the professional medical markets."
Jack Moran, President of MCA commented: "Our sales representatives are
all primed for the task at hand and look forward to achieving together with
|SOURCE SPO Medical Inc|
Copyright©2009 PR Newswire.
All rights reserved